BENSALEM, Pa. –Law Offices of Howard G. Smith announces an investigation on behalf of Zymeworks Inc. (“Zymeworks” or the “Company”) (NYSE: ZYME) investors concerning the Company and its officers’ possible violations of federal securities laws.
On April 28, 2017, Zymeworks sold 4.5 million shares of stock in its initial public offering (“IPO”), raising $58.50 million in new capital. Since the IPO, Zymeworks stock price has collapsed. The investigation concerns whether Zymeworks’ IPO registration statement contained false or misleading statements.
If you purchased Zymeworks securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at 215-638-4847, toll-free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com